Literature DB >> 12353193

Varicella-zoster virus: atypical presentations and unusual complications.

John W Gnann1.   

Abstract

Varicella-zoster virus (VZV) is the etiologic agent of varicella (primary infection) and herpes zoster (reactivation of latent infection). Although varicella is most often a relatively benign and self-limited childhood illness, the disease can be associated with a variety of serious and potentially lethal complications in both immunocompetent and immunocompromised persons. One complication of varicella that appears to be increasing in frequency is serious bacterial soft tissue infections caused by group A streptococci. Issues related to management of varicella become especially complex when varicella involves pregnant women or susceptible neonates. Herpes zoster can be associated with a variety of neurologic complications, including a syndrome of delayed contralateral hemiparesis. Neurologic complications of herpes zoster, including chronic encephalitis, occur with increased frequency in AIDS patients. VZV retinitis is a potentially sight-threatening complication that occurs in both immunocompetent and immunocompromised persons. Current knowledge regarding pathogenesis and antiviral therapy is reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353193     DOI: 10.1086/342963

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  67 in total

1.  Aseptic meningitis in neonatal varicella complicated by Escherichia coil sepsis.

Authors:  Maria Serenella Pignotti; Giuseppe Indolfi; Antonio Messineo; Gianpaolo Donzelli
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

2.  Primary varicella in an immunocompetent adult.

Authors:  Izikson Leonid; Lilly Evelyn
Journal:  J Clin Aesthet Dermatol       Date:  2009-08

3.  Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination.

Authors:  Peter Norberg; Jan-Ake Liljeqvist; Tomas Bergström; Scott Sammons; D Scott Schmid; Vladimir N Loparev
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Multi-organ involvement secondary to varicella zoster virus, herpes simplex virus and cytomegalovirus in an immunocompromised patient.

Authors:  Ripal Jariwala; Kristen Zeitler; Nicole D Riddle; Chakrapol Sriaroon
Journal:  BMJ Case Rep       Date:  2019-03-31

5.  [Therapy of herpes zoster].

Authors:  A J Ullmann
Journal:  Internist (Berl)       Date:  2008-07       Impact factor: 0.743

Review 6.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

7.  Bullous varicella in an immunocompetent infant.

Authors:  Siham Mansouri; Sara Mai; Badr Hassam; Laila Benzekri
Journal:  BMJ Case Rep       Date:  2019-03-31

8.  Varicella bullosa in an adult.

Authors:  Preema Sinha; Saikat Bhattacharjee; Manas Chatterjee
Journal:  Med J Armed Forces India       Date:  2016-12-01

9.  Atypical, severe presentation of chickenpox.

Authors:  Nataliya Banadyha; Igor Rogalskyy; Roman Komorovsky
Journal:  World J Pediatr       Date:  2018-09-28       Impact factor: 2.764

10.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.